MicroRNA has been found to have regulatory in many cancer-related processes in the human body that researchers in Israel are capitalizing on as a sure way of detecting squamous and non-squamous cells that are sure sign of lung cancer. This is vital for current available treatments for non-squamous cancers are deadly to squamous cancer sufferers and vice versa. On the other hand, Italian researchers have devised a way by which oncologists can check for three genetic markers as determining factor of the best approach treatment is to take. This allows better diagnosis with treatment customized to individual patients giving the oncologist the best possible chances of success and the patient recovery. To determine the advancement of the disease greatly enhances our ability to treat and provide the best possible medical solutions for a particular disease. This for m of diagnosis is being tested out for other forms of cancer which can greatly increase survivability rates of sufferers. It may also aid scientists in providing better prevention drugs or through genetic analyses be able to say who is susceptible of what thus giving patients time to adjust their lifestyles to avoid contracting that form of the disease.